SARS Capital Revenue and Competitors
Employee Data
- SARS Capital has 107 Employees.
- SARS Capital grew their employee count by 0% last year.
SARS Capital's People
| Name | Title | Email/Phone |
|---|
SARS Capital Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 4 | -50% | N/A | N/A |
#2 | N/A | 31 | 7% | N/A | N/A |
#3 | N/A | 156 | 32% | N/A | N/A |
#4 | $75M | 275 | 0% | N/A | N/A |
#5 | $15M | 54 | 6% | N/A | N/A |
#6 | $1.7M | 6 | -82% | N/A | N/A |
#7 | $3.5M | 16 | 7% | N/A | N/A |
#8 | $7.5M | 81 | 19% | N/A | N/A |
#9 | N/A | 50 | 32% | N/A | N/A |
#10 | N/A | 3 | -25% | N/A | N/A |
What Is SARS Capital?
N/A
Total Funding
107
Number of Employees
N/A
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SARS Capital News
2022-04-20 - Low Vaccination Rates in Children, Non-Adherence to COVID ...
Nearly 100 school children in the NCR region of the capital have been infected with SARS-CoV-2 the virus causing the COVID-19 disease in...
2022-04-17 - SpikImm, a Biotech Company Founded by Truffle Capital and ...
SpikImm, a Biotech Company Founded by Truffle Capital and Institut Pasteur, Announces That Its Monoclonal Antibody Neutralises All SARS-COV-2...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $23.5M | 107 | 7% | N/A |
#2 | $15.5M | 107 | 15% | N/A |
#3 | N/A | 107 | 7% | N/A |
#4 | $15.5M | 107 | 5% | N/A |
#5 | $7.8M | 107 | 34% | N/A |